A Machine Learning Model for Prostate Cancer Prediction in Korean Men
Authors:
Open Access
- 30 November 2024
- journal article
- Published by Korean Urological Oncology Society in Journal of Urologic Oncology
- Vol. 22 (3) , 201-210
Abstract
Purpose: Unnecessary prostate biopsies for detecting prostate cancer (PCa) should be minimized. Therefore, this study developed a machine learning (ML) model to predict PCa in Korean men and evaluated its usability.Materials and Methods: We retrospectively analyzed clinical data from 928 patients who underwent prostate biopsies at Kangwon National University Hospital between May 2013 and May 2023. Of these, 377 (41.6%) were diagnosed with PCa, and 551 (59.4%) did not have cancer. For external validation, clinical data from 385 patients aged 48–89 years who underwent prostate biopsies from September 2005 to September 2023 at Wonju Severance Christian Hospital were also included. Twenty-two clinical features were used to develop an ML model to predict PCa. Features were selected based on their contributions to model performance, leading to the inclusion of 15 features. A meta-learner was constructed using logistic regression to predict the probability of PCa, and the classifier was trained and validated on randomly extracted training and test sets at an 8:2 ratio.Results: The prostate health index, prostate volume, age, nodule on digital rectal examination, and prostate-specific antigen were the top 5 features for predicting PCa. The area under the receiver operating characteristic curve (AUC) of the meta-learner logistic regression model was 0.89, and the accuracy, sensitivity, and specificity were 0.828, 0.711, and 0.909, respectively. Our model also showed excellent prediction performance for high-grade PCa, with a Gleason score of 7 or higher and an AUC of 0.903. Furthermore, we evaluated the performance of the model using external cohort clinical data and achieved an AUC of 0.863.Conclusions: Our ML model excelled in predicting PCa, specifically clinically significant PCa. Although extensive cross-validation in other clinical cohorts is needed, this ML model is a promising option for future diagnostics.Keywords
Funding Information
- Ministry of SMEs and Startups (1425170909)
This publication has 24 references indexed in Scilit:
- A novel approach to explain the black-box nature of machine learning in compressive strength predictions of concrete using Shapley additive explanations (SHAP)Case Studies in Construction Materials, 2022
- Artificial intelligence and the future of global healthThe Lancet, 2020
- Ensemble learning: A surveyWIREs Data Mining and Knowledge Discovery, 2018
- Pre-trained convolutional neural networks as feature extractors for tuberculosis detectionComputers in Biology and Medicine, 2017
- Recent progress and perspectives on prostate cancer biomarkersInternational Journal of Clinical Oncology, 2016
- PSA and beyond: alternative prostate cancer biomarkersCellular Oncology, 2016
- Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate CancerUrology, 2014
- Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal ExaminationUrology, 2014
- Quantifying the role of PSA screening in the US prostate cancer mortality declineCancer Causes & Control, 2007
- Prostate Specific Antigen: A Critical Assessment of the Most Useful Tumor Marker for Adenocarcinoma of the ProstateJournal of Urology, 1991